In a research report issued Monday, Maxim analyst Jason McCarthy reiterated a Buy rating on shares of Inovio Pharmaceuticals Inc (NASDAQ:INO), with a price target …
Healthcare analysts explain why they are bullish on biotech firm Relypsa Inc (NASDAQ:RLYP) and vaccine developer Inovio Pharmaceuticals Inc (NASDAQ:INO) regarding drug launch data …
Analysts weighed in on biotech companies Opko Health Inc.(NYSE:OPK) and Inovio Pharmaceuticals Inc (NASDAQ:INO) in light of new reports and pipeline updates from the …
Partnership terminations, government investigations, pipeline updates, and advancements in new products mark this week’s earnings reports from Valeant Pharmaceuticals Intl Inc (NYSE:VRX), MannKind Corporation …
Analysts are weighing in on obesity-device maker EnteroMedics Inc (NASDAQ:ETRM), stem cell company Athersys, Inc. (NASDAQ:ATHX) and cancer vaccine maker Inovio Pharmaceuticals Inc (NASDAQ:INO), with price targets ranging from …
Maxim’s healthcare analyst Jason McCarthy weighed in today on cancer-drug maker Juno Therapeutics Inc (NASDAQ:JUNO) and cancer-vaccine maker Inovio Pharmaceuticals Inc (NASDAQ:INO). The analyst reflects on Juno’s opportunity in …
Seadrill Ltd (NYSE:SDRL) is up over 4% in pre-market trading, as the price of oil is edging up while major crude producing countries discuss …
Inovio Pharmaceuticals Inc (NASDAQ:INO) announced that preclinical testing of its synthetic vaccine for the Zika virus induced robust and durable immune responses, demonstrating …
Healthcare analysts weighed in today on biotech companies Relypsa Inc (NASDAQ:RLYP) and Inovio Pharmaceuticals Inc (NASDAQ:INO), as Relypsa gained Medicare coverage for Veltassa, …
Healthcare analysts weighed in today on biotech stocks Inovio Pharmaceuticals Inc (NASDAQ:INO) and Neuralstem, Inc. (NASDAQ:CUR), while both stocks were among the top performers from the …
